1. Shin J, Cho MC. Updated reasons and clinical implications of new Korean hypertension guidelines for cardiologists. Korean Circ J. 2020; 50:476–484. PMID:
32281319.
2. SPRINT Research Group. Wright JT Jr, Williamson JD, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015; 373:2103–2116. PMID:
26551272.
3. Zhang W, Zhang S, Deng Y, et al. Trial of intensive blood-pressure control in older patients with hypertension. N Engl J Med. 2021; 385:1268–1279. PMID:
34491661.
4. Jo SH, Kim SA, Park KH, Kim HS, Han SJ, Park WJ. Self-blood pressure monitoring is associated with improved awareness, adherence, and attainment of target blood pressure goals: prospective observational study of 7751 patients. J Clin Hypertens (Greenwich). 2019; 21:1298–1304. PMID:
31393062.
5. Agarwal R, Bills JE, Hecht TJ, Light RP. Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis. Hypertension. 2011; 57:29–38. PMID:
21115879.
6. Lee CJ, Park S. The role of home blood pressure telemonitoring for blood pressure control. Pulse (Basel). 2016; 4:78–84. PMID:
27752479.
7. Omboni S, Gazzola T, Carabelli G, Parati G. Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens. 2013; 31:455–467. PMID:
23299557.
8. Chaikijurajai T, Laffin LJ, Tang WHW. Artificial intelligence and hypertension: recent advances and future outlook. Am J Hypertens. 2020; 33:967–974. PMID:
32615586.
9. Choi DJ, Park JJ, Park SJ, et al. Self-Monitoring of blood pressure and Feed-back using APP In TReatment of UnconTrolled Hypertension (SMART-BP): a randomized clinical trial. Korean Circ J. 2022; 52:785–794.
10. Gerke S, Minssen T, Cohen G. Ethical and legal challenges of artificial intelligence-driven healthcare. Artificial Intelligence in Healthcare. 2020. p. 295–336.